Analysts have been eager to weigh in on the Healthcare sector with new ratings on Roche Holding AG (RHHVF – Research Report), Roivant Sciences (ROIV – Research Report) and Biophytis (BPTS – Research Report).
Roche Holding AG (RHHVF)
Deutsche Bank analyst Emmanuel Papadakis maintained a Hold rating on Roche Holding AG today and set a price target of CHF300.00. The company’s shares closed last Thursday at $319.25, close to its 52-week low of $299.01.
According to TipRanks.com, Papadakis is a 4-star analyst with an average return of
Roche Holding AG has an analyst consensus of Moderate Buy, with a price target consensus of $386.49.
See the top stocks recommended by analysts >>
Roivant Sciences (ROIV)
H.C. Wainwright analyst Douglas Tsao maintained a Buy rating on Roivant Sciences today and set a price target of $14.00. The company’s shares closed last Thursday at $5.80.
According to TipRanks.com, Tsao is a 4-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Roivant Sciences with a $10.50 average price target.
Biophytis (BPTS)
In a report released today, Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on Biophytis, with a price target of $15.00. The company’s shares closed last Thursday at $0.50, close to its 52-week low of $0.35.
According to TipRanks.com, Pantginis is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of
Biophytis has an analyst consensus of Moderate Buy, with a price target consensus of $15.00.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
